Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow AVANOS MEDICAL, INC.

Get SEC filing alerts via email and in your feed for AVANOS MEDICAL, INC.

AVNS

AVANOS MEDICAL, INC.

About AVANOS MEDICAL, INC.

Avanos Medical, Inc. develops, manufactures, and markets medical devices focused on Digestive Health and Pain Management and Recovery. Its key products include enteral feeding tubes, neonatal feeding solutions, and non-opioid pain relief therapies such as surgical pain pumps and radiofrequency ablation devices. Serving hospitals and healthcare providers globally, Avanos emphasizes clinically effective, reliable solutions that improve patient outcomes and reduce healthcare costs through a broad distribution network and strong customer engagement.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from AVANOS MEDICAL, INC.

1
1
AVANOS MEDICAL, INC. Avanos Medical Reports 8.8% Net Sales Increase to $182.2 Million in Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
AVANOS MEDICAL, INC. Avanos Medical Reports $701.2M Revenue and $72.9M Net Loss for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
AVANOS MEDICAL, INC. Avanos Medical Reports $1.4 Million Net Loss in Q3 2025, Revenue Increases 4.3%

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
AVANOS MEDICAL, INC. Avanos Medical Reports $76.8 Million Net Loss in Q2 2025 Amid Restructuring Efforts

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
AVANOS MEDICAL, INC. Avanos Medical Reports $167.5 Million in Net Sales for Q1 2025, Achieves Net Income of $6.6 Million

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
AVANOS MEDICAL, INC. Avanos Medical Reports 2.2% Increase in Net Sales, Faces Operating Loss in 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
AVANOS MEDICAL, INC. Avanos Medical Reports Mixed Q3 and 9M 2024 Financial Results, Shows Improvement in Profitability

Via official filing (AI summary) | over 1 year ago | 0 comments